International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Ultrarapid Opioid Detoxification: Current Status in Iran and Controversies

Seyyed Mojtaba Yassini Ardekani 1 , * and Sara Yassini Ardekani 2
Authors Information
1 Department of Psychiatry, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, IR Iran
2 Department of Medicine, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, IR Iran
Article information
  • International Journal of High Risk Behaviors and Addiction: December 01, 2013, 2 (3); 96-99
  • Published Online: December 12, 2013
  • Article Type: Editorial
  • Received: June 30, 2013
  • Revised: September 10, 2013
  • Accepted: September 23, 2013
  • DOI: 10.5812/ijhrba.13140

To Cite: Yassini Ardekani S M, Yassini Ardekani S. Ultrarapid Opioid Detoxification: Current Status in Iran and Controversies, Int J High Risk Behav Addict. 2013 ; 2(3):96-99. doi: 10.5812/ijhrba.13140.

Copyright © 2013, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Rapid and Ultra-rapid Detoxification
3. UROD in Iran
4. Available Evidences
5. Controversies
6. Author's Experiences
7. Clients
8. Procedure
9. Cardiovascular Changes During Procedure
10. Withdrawal Syndrome
11. Complications
12. Follow Up
13. Conclusions
  • 1. Public Policy Statementon Rapid and Ultra Rapid Opioid Detoxification. 2005;
  • 2. Collins ED, Kleber HD, Whittington RA, Heitler NE. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. JAMA. 2005; 294(8): 903-13[DOI][PubMed]
  • 3. Tretter F, Burkhardt D, Bussello-Spieth B, Reiss J, Walcher S, Buchele W. Clinical experience with antagonist-induced opiate withdrawal under anaesthesia. Addiction. 1998; 93(2): 269-75[PubMed]
  • 4. Blachley P, Casey D, Marcel L, Demey DD. Developments in the field of drug abuse. 1975; : 327-36
  • 5. Loimer N, Schmid RW, Presslich O, Lenz K. Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment. J Psychiatr Res. 1989; 23(1): 81-6[PubMed]
  • 6. Riordan CE, Kleber HD. Rapid opiate detoxification with clonidine and naloxone. Lancet. 1980; 1(8177): 1079-80[PubMed]
  • 7. Vining E, Kosten TR, Kleber HD. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br J Addict. 1988; 83(5): 567-75[PubMed]
  • 8. Singh J, Basu D. Ultra-rapid opioid detoxification: current status and controversies. J Postgrad Med. 2004; 50(3): 227-32[PubMed]
  • 9. Johnson TS, Carr M. Naltrexone-mediated opiate detoxification: a matter of terminology! Addict Biol 2003; 8(3): 267-9[PubMed]
  • 10. Substance use disorder. Ministry of health and medical education, deputy for prevention and treatment of substance use disorder. 2007;
  • 11. O'Connor PG, Kosten TR. Rapid and ultrarapid opioid detoxification techniques. JAMA 1998; 279(3): 229-34
  • 12. Yassini M, Larigani KH, Rafati A. URD and Severity of Withdrawal Symptoms. World J Med Sci. 2006; 1(2): 86-9
  • 13. Seoane A, Carrasco G, Cabre L, Puiggros A, Hernandez E, Alvarez M, et al. Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success. Br J Psychiatry. 1997; 171: 340-5[PubMed]
  • 14. Bell J, Kimber J, Lintzeris N. Guidelines for rapid detoxification from opioids. NSW Health, circular. 2001;
  • 15. Hensel M, Kox WJ. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts. Acta Anaesthesiol Scand. 2000; 44(3): 326-33[PubMed]
  • 16. Cucchia Anne Thérèse, Monnat Martine, Spagnoli Jacques, Ferrero François, Bertschy Gilles. Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results. Drug Alcohol Dependenc. 1998; 52(3): 243-50
  • 17. Laheij RJ, Krabbe PF, de Jong CA. Rapid heroin detoxification under general anesthesia. JAMA. 2000; 283(9): 1143[PubMed]
  • 18. Lawental E. Ultra rapid opiate detoxification as compared to 30-day inpatient detoxification program--a retrospective follow-up study. J Subst Abuse. 2000; 11(2): 173-81[PubMed]
  • 19. Krabbe PF, Koning JP, Heinen N, Laheij RJ, van Cauter RM, De Jong CA. Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences. Addict Biol. 2003; 8(3): 351-8[DOI][PubMed]
  • 20. Bochud Tornay C, Favrat B, Monnat M, Daeppen JB, Schnyder C, Bertschy G, et al. Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results. Drug Alcohol Depend. 2003; 69(3): 283-8[PubMed]
  • 21. Loimer N, Linzmayer L, Grunberger J. Comparison between observer assessment and self rating of withdrawal distress during opiate detoxification. Drug Alcohol Depend. 1991; 28(3): 265-8[PubMed]
  • 22. Elman Igor, D'Ambra Michael N, Krause Sara, Breiter Hans, Kane Martha, Morris Robert, et al. Ultrarapid opioid detoxification: effects on cardiopulmonary physiology, stress hormones and clinical outcomes. Drug and alcohol dependence. 2001; 61(2): 163-172
  • 23. Greenberg M. Ultrarapid opioid detoxification of two children with congenital heart disease. J Addict Dis. 2000; 19(4): 53-8[DOI][PubMed]
  • 24. Bulthuis D, Diaz JE. Ultrarapid opiate detoxification. Ann Emerg Med. 2000; 35(1): 100-1[PubMed]
  • 25. Josefson D. US scientist plans human cloning clinic. BMJ. 1998; 316(7126): 167[PubMed]
  • 26. Hamilton RJ, Olmedo RE, Shah S, Hung OL, Howland MA, Perrone J, et al. Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets. Acad Emerg Med. 2002; 9(1): 63-8[PubMed]
  • 27. Rabinowitz J, Cohen H, Kotler M. Outcomes of ultrarapid opiate detoxification combined with naltrexone maintenance and counseling. Psychiatr Serv. 1998; 49(6): 831-3[PubMed]
  • 28. Public policy statement on opioid antagonist agent detoxification under sedation or anesthesia (OADUSA). American Society of Addiction Medicine (ASAM). J Addict Dis. 2000; 19(4): 109-12[PubMed]
  • 29. Yassini M, Rafati A. Introduction to addiction and management of drug abuse. 2004;
  • 30. Yassini M, Khosravi LH. Study of short term results of ultra-rapid detoxification in 25 cases of opioid dependence. J Shahid Sadoughi Univ Med Sci Health Service. 2002; 9(4): 3-9
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments